Related Experiment Video

Updated: Oct 29, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.2K

BCAT1 knockdown-mediated suppression of melanoma cell proliferation and migration is associated with reduced

Bingxia Zhang1,2, Fang Xu1, Kaijuan Wang3

  • 1Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University Henan, China.

American Journal of Cancer Research
|July 12, 2021
PubMed

Insights

Branched-chain amino acid transaminase 1 (BCAT1) is overexpressed in melanoma. Inhibiting BCAT1 suppressed cancer growth and migration, suggesting BCAT1 as a potential therapeutic target for melanoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Malignant melanoma exhibits a high mutation rate, leading to frequent therapeutic resistance.
  • There is a significant unmet need for novel melanoma treatment strategies.
  • Branched-chain amino acid transaminase 1 (BCAT1) is increasingly recognized for its role in cancer progression across various malignancies.

Purpose of the Study:

  • To investigate the functional role of BCAT1 in the proliferation and migration of malignant melanoma.
  • To determine if BCAT1 is a viable therapeutic target for melanoma.

Main Methods:

  • Analysis of BCAT1 expression in human and mouse melanoma tissues.
  • In vitro studies using a mouse B16 melanoma cell line with BCAT1 knockdown.
  • Assessment of cell proliferation, migration, and oxidative phosphorylation levels.

Main Results:

  • BCAT1 was found to be overexpressed in both human and mouse malignant melanoma samples.
  • Suppression of BCAT1 (knockdown) significantly inhibited melanoma cell proliferation and migration.
  • BCAT1 knockdown was correlated with a reduction in oxidative phosphorylation.

Conclusions:

  • BCAT1 plays a critical role in the progression of malignant melanoma.
  • BCAT1 is a promising therapeutic target for developing novel melanoma treatments.
  • Targeting BCAT1 may offer a new strategy to overcome therapeutic resistance in melanoma.
Keywords:
Malignant melanomabranched-chain amino acid transaminase 1branched-chain amino acidsglycolysismigrationoxidative phosphorylationproliferation

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.1K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.2K